Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

Hwail Pharmaceutical Revenue

Hwail Pharmaceutical had revenue of 24.46B KRW in the quarter ending June 30, 2026, a decrease of -0.75%. This brings the company's total for the last twelve months to 107.87B, down -4.84% year-over-year. In the year 2016, Hwail Pharmaceutical had annual revenue of 111.52B with 5.08% growth. That makes Hwail Pharmaceutical the 24,327th largest company in the world by revenue and 1,397th in South Korea.

• Revenue (ttm): 107.87B
• Revenue Growth: -4.84%
• P/S Ratio: 0.43
• Revenue / Employee: 829.81M
• Employees: 130
• Market Cap: 45.86B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2016	111.52B	5.39B	5.08%
Dec 31, 2015	106.13B	10.03B	10.43%
Dec 31, 2014	96.10B	1.94B	2.06%
Dec 31, 2013	94.17B	2.33B	2.54%
Dec 31, 2012	91.83B	13.74B	17.59%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error